Announce Date | 05/02/2025 |
EPS Normalized Actual | $1.03 (Beat by $0.075) |
EPS GAAP Actual | $1.03 (Beat by $0.075) |
Revenue Actual | $3.066B |
Revenue Surprise | Beat by $3066M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.03129 |
EPS GAAP Estimate | $1.03129 |
Revenue Estimate | $3.197438037B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 6.15 | 11.99 | 5.98907 | 6.25121 | 1 |
Dec 2027 | 5.5 | 13.4 | 5.39371 | 5.58646 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -1.41 | -1.41 | 3.066B | 4.4% | 3066M |
FQ4 2024 (Dec 2024) | -0.72 | -0.72 | 2.898B | -7.11% | 2898M |
FQ3 2024 (Sep 2024) | 1.15 | 1.15 | 3.192B | -3.92% | 3192M |
FQ2 2024 (Jun 2024) | 0.43 | 0.43 | 3.171B | 2.43% | 3171M |
FQ1 2024 (Mar 2024) | 0.43 | 0.43 | 2.931B | -2.97% | 2931M |
FQ4 2023 (Dec 2023) | 0.23 | 0.23 | 3.104B | 0% | 3104M |
FQ3 2023 (Sep 2023) | 0.71 | 0.71 | 3.317B | 0% | 3317M |
FQ2 2023 (Jun 2023) | -0.29 | -0.29 | 3.094B | -7.37% | 3094M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.03129
Consensus Revenue Estimates
3.197438037B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.5062 | -- | 1.46658 | 1.53035 | 3 |
FQ3 2027 (Sep 2027) | 1.5826 | -- | 1.54097 | 1.60797 | 3 |
FQ2 2027 (Jun 2027) | 1.4839 | -- | 1.44487 | 1.50769 | 3 |
FQ1 2027 (Mar 2027) | 1.201 | -- | 1.16941 | 1.22025 | 3 |
FQ4 2026 (Oct 2026) | 1.3164 | -- | 1.29551 | 1.33957 | 4 |
FQ3 2026 (Jul 2026) | 1.179 | -- | 1.16029 | 1.19975 | 4 |
FQ2 2026 (Jun 2026) | 1.18 | -- | 1.14996 | 1.2299 | 4 |
FQ1 2026 (Mar 2026) | 0.98 | 243.88 | 0.95505 | 1.02144 | 4 |
FQ4 2025 (Oct 2025) | 1.12883 | 163.78 | 1.11092 | 1.1487 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.57B | -- | 3.5B | 3.61B | 4 |
FQ3 2027 (Sep 2027) | 3.7B | -- | 3.63B | 3.75B | 4 |
FQ2 2027 (Jun 2027) | 3.66B | -- | 3.58B | 3.7B | 4 |
FQ1 2027 (Mar 2027) | 3.41B | -- | 3.34B | 3.45B | 4 |
FQ4 2026 (Oct 2026) | 3.49B | -- | 3.45B | 3.54B | 4 |
FQ3 2026 (Jul 2026) | 3.33B | -- | 3.29B | 3.37B | 6 |
FQ2 2026 (Jun 2026) | 3.29B | -- | 3.23B | 3.4B | 6 |
FQ1 2026 (Mar 2026) | 3.07B | 0.04 | 3.01B | 3.17B | 4 |
FQ4 2025 (Oct 2025) | 3.37B | 13.97 | 3.33B | 3.41B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -1.41 | -1.41 | 100% | |
FQ4 2024 (Dec 2024) | -0.72 | -0.72 | 100% | |
FQ3 2024 (Sep 2024) | 1.15 | 1.15 | 100% | |
FQ2 2024 (Jun 2024) | 0.43 | 0.43 | 100% | |
FQ1 2024 (Mar 2024) | 0.43 | 0.43 | 100% | |
FQ4 2023 (Dec 2023) | 0.23 | 0.23 | 100% | |
FQ3 2023 (Sep 2023) | 0.71 | 0.71 | 100% | |
FQ2 2023 (Jun 2023) | -0.29 | -0.29 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $3.07B | $3066M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.9B | $2898M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.19B | $3192M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.17B | $3171M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.93B | $2931M | 100% |
FQ4 2023 (Dec 2023) | $0B | $3.1B | $3104M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.32B | $3317M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.09B | $3094M | 100% |